Literature DB >> 11336660

Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction.

A Gangloff1, A Garneau, Y W Huang, F Yang, S X Lin.   

Abstract

Human oestrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD1) catalyses the final step in the biosynthesis of all active oestrogens. Here we report the steady-state kinetics for 17beta-HSD1 at 37 degrees C and pH 7.5, using a homogeneous enzyme preparation with oestrone, dehydroepiandrosterone (DHEA) or dihydrotestosterone (DHT) as substrate and NADP(H) as the cofactor. Kinetic studies made over a wide range of oestrone concentrations (10 nM-10 microM) revealed a typical substrate-inhibition phenomenon. Data analysis using the substrate-inhibition equation v=V.[s]/[K(m)+[s](1+[s]/K(i))] gave a K(m) of 0.07+/-0.01 microM, a k(cat) (for the dimer) of 1.5+/-0.1 s(-1), a specificity of 21 microM(-1) x s(-1) and a K(i) of 1.3 microM. When NADH was used instead of NADPH, substrate inhibition was no longer observed and the kinetic constants were significantly modified to 0.42+/-0.07 microM for the K(m), 0.8+/-0.04 s(-1) for the k(cat) and 1.9 microM(-1) x s(-1) for the specificity. The modification of an amino acid in the cofactor-binding site (Leu36Asp) eliminated the substrate inhibition observed in the presence of NADPH, confirming the NADPH-dependence of the phenomenon. The possible formation of an enzyme-NADP(+)-oestrone dead-end complex during the substrate-inhibition process is supported by the competitive inhibition of oestradiol oxidation by oestrone. Kinetic studies performed with either DHEA (K(m)=24+/-4 microM; k(cat)=0.47+/-0.06 s(-1); specificity=0.002 microM(-1) x s(-1)) or DHT (K(m)=26+/-6 microM; k(cat)=0.2+/-0.02 s(-1); specificity=0.0008 microM(-1) x s(-1)) in the presence of NADP(H) resulted in low specificities and no substrate inhibition. Taken together, our results demonstrate that the high specificity of 17beta-HSD1 towards oestrone is coupled with an NADPH-dependent substrate inhibition, suggesting that both the specificity and the enzyme control are provided for the cognate substrate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336660      PMCID: PMC1221836          DOI: 10.1042/0264-6021:3560269

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Novel compounds inhibit estrogen formation and action.

Authors:  C Labrie; C Martel; J M Dufour; C Lévesque; Y Mérand; F Labrie
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

2.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.

Authors:  R Higuchi; B Krummel; R K Saiki
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

3.  Dehydroepiandrosterone and dihydrotestosterone recognition by human estrogenic 17beta-hydroxysteroid dehydrogenase. C-18/c-19 steroid discrimination and enzyme-induced strain.

Authors:  Q Han; R L Campbell; A Gangloff; Y W Huang; S X Lin
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

4.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

5.  Cancer statistics, 2000.

Authors:  R T Greenlee; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  2000 Jan-Feb       Impact factor: 508.702

6.  Redox cycles in trimethylamine dehydrogenase and mechanism of substrate inhibition.

Authors:  P Roberts; J Basran; E K Wilson; R Hille; N S Scrutton
Journal:  Biochemistry       Date:  1999-11-09       Impact factor: 3.162

7.  Dehydroepiandrosterone is a substrate for estradiol 17 beta-dehydrogenase from human placenta.

Authors:  G Mendoza-Hernández; M Calcagno; H R Sánchez-Nuncio; J C Díaz-Zagoya
Journal:  Biochem Biophys Res Commun       Date:  1984-02-29       Impact factor: 3.575

8.  Liver alcohol dehydrogenase: substrate inhibition and competition between substrates.

Authors:  Y Pocker; K W Raymond
Journal:  Alcohol       Date:  1985 Jan-Feb       Impact factor: 2.405

9.  Immunological analysis of 17 beta-hydroxysteroid dehydrogenase in benign and malignant human breast tissue.

Authors:  M Poutanen; V Isomaa; V P Lehto; R Vihko
Journal:  Int J Cancer       Date:  1992-02-01       Impact factor: 7.396

10.  Metabolism of [3H]oestradiol in vivo by normal breast and tumour tissue in postmenopausal women.

Authors:  R C Bonney; M J Reed; P A Beranek; M W Ghilchik; V H James
Journal:  J Steroid Biochem       Date:  1986-01       Impact factor: 4.292

View more
  9 in total

1.  Structural and kinetic basis for substrate selectivity in Populus tremuloides sinapyl alcohol dehydrogenase.

Authors:  Erin K Bomati; Joseph P Noel
Journal:  Plant Cell       Date:  2005-04-13       Impact factor: 11.277

2.  Removal of substrate inhibition and increase in maximal velocity in the short chain dehydrogenase/reductase salutaridine reductase involved in morphine biosynthesis.

Authors:  Jörg Ziegler; Wolfgang Brandt; René Geissler; Peter J Facchini
Journal:  J Biol Chem       Date:  2009-07-30       Impact factor: 5.157

3.  Atomic structure of salutaridine reductase from the opium poppy (Papaver somniferum).

Authors:  Yasuhiro Higashi; Toni M Kutchan; Thomas J Smith
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

Review 4.  Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism.

Authors:  Tea Lanišnik Rižner; Trevor M Penning
Journal:  Steroids       Date:  2013-11-01       Impact factor: 2.668

5.  Insights in 17beta-HSD1 enzyme kinetics and ligand binding by dynamic motion investigation.

Authors:  Matthias Negri; Maurizio Recanatini; Rolf W Hartmann
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

6.  The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cells.

Authors:  Chen-Yan Zhang; Jiong Chen; Da-Chuan Yin; Sheng-Xiang Lin
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

7.  Hydroxybenzothiazoles as new nonsteroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1).

Authors:  Alessandro Spadaro; Matthias Negri; Sandrine Marchais-Oberwinkler; Emmanuel Bey; Martin Frotscher
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

8.  The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer.

Authors:  Maša Sinreih; Tamara Knific; Maja Anko; Neli Hevir; Katja Vouk; Aleš Jerin; Snježana Frković Grazio; Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2017-06-23       Impact factor: 5.810

9.  Genome-Wide Identification of mRNAs, lncRNAs, and Proteins, and Their Relationship With Sheep Fecundity.

Authors:  Chunxin Wang; Yunhui Zhao; ZhiYu Yuan; Yujin Wu; Zhuo Zhao; Cuiling Wu; Jian Hou; Mingxin Zhang
Journal:  Front Genet       Date:  2022-02-08       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.